A Long-Term Follow-up Study of the Severe Parkinson’s Disease Patients Administered the IPS101A Gene Therapy Product.

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Parkinson Disease; Parkinson’s Disease Sponsors: Innopeutics Corporation Not yet recruiting Conditions: Parkinson Disease; Parkinson’s Disease Sponsors: Innopeutics Corporation Not yet recruiting 

VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Brain Cancer Interventions: Drug: Vorasidenib; Drug: Lomustine Sponsors: Megan Mantica; Institut de Recherches Internationales Servier Not yet recruiting Conditions: Brain Cancer Interventions: Drug: Vorasidenib; Drug: Lomustine Sponsors: Megan Mantica;...

Regulating Together for Intellectual Disability and Autism: A Group Behavioral Therapy for for Emotion Dysregulation

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Autism; Intellectual Disabilities With Other Behavioral Symptoms; Intellectual Disability Interventions: Behavioral: Regulating Together group therapy Sponsors: Children’s Mercy Hospital Kansas City; National Institutes of Health (NIH); National...

Effects of Progressive Muscle Relaxation Exercise and Finger Grip Exercise on Stress, Anxiety, Fatigue, Sleep Quality, and Physiological Parameters in Pregnant Women With Preeclampsia

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Pregnancy; Preeclampsia Interventions: Other: Progressive Muscle Relaxation Exercise; Other: Finger Grip Exercise Sponsors: Hatice Nur Nefes Pala Enrolling by invitation Conditions: Pregnancy; Preeclampsia Interventions: Other: Progressive Muscle...

The Pharmacokinetics and Pharmacodynamics Study of CG-0255 Besylate and Plavix® in Healthy Participants

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Acute Coronary Syndromes (ACS); Recent Myocardial Infarction; Recent Stroke; Peripheral Arterial Disease Interventions: Drug: CG-0255 Besylate for Injection; Drug: CG-0255 Besylate Capsule; Drug: Clopidogrel Sponsors: Shanghai CureGene Pharmaceutical...

Post-Operative Spinal Block Duration and Pain Relief After Hip Replacement Surgery: Comparing Single-Shot Spinal Ropivacaine and Bupivacaine

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Hip Osteoarthritis; Hip Arthroplasty Replacement; Postoperative Pain After Ambulatory Surgery Interventions: Drug: Spinal Anesthesia with Ropivacaine 15 mg (5 mg/ml); Drug: Spinal Anesthesia with Bupivacaine 11 mg (5 mg/ml) Sponsors: University of Turku;...